XML 41 R31.htm IDEA: XBRL DOCUMENT v3.21.2
SHARE CAPITAL AND OTHER EQUITY INSTRUMENTS (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Feb. 11, 2021
Jan. 14, 2021
Sep. 30, 2021
Jun. 30, 2021
Mar. 31, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross             80,000  
[custom:InducementExpense]         $ 298,714  
Stock Issued During Period, Value, Restricted Stock Award, Gross           6,966,721  
Share-based Payment Arrangement, Option [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Share-based Payment Arrangement, Expense     4,683     0 4,683 $ 0
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount     504,903       $ 504,903  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross         560,404      
Equity Option [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Weighted average amortization term             2 years 10 months 24 days  
Restricted Stock Units (RSUs) [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Share-based Payment Arrangement, Expense     458,308     0 $ 4,710,225 0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross         325,410      
Restricted Stock [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Share-based Payment Arrangement, Expense     23,995     $ 0 80,109 $ 0
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount     24,012       $ 24,012  
Weighted average amortization term             3 months  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross         42,125      
[custom:InducementExpense]         $ 298,714      
General and Administrative Expense [Member] | Restricted Stock Units (RSUs) [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Share-based Payment Arrangement, Expense     315,929       $ 4,592,748  
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount     7,908,006       $ 7,908,006  
Weighted average amortization term             3 years 6 months 25 days  
Research and Development Expense [Member] | Restricted Stock Units (RSUs) [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Share-based Payment Arrangement, Expense     $ 118,474       $ 118,474  
Offering [Member] | Expense [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Proceeds from Issuance Initial Public Offering $ 527,000 $ 663,000            
Common Stock [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Stock Issued During Period, Value, Restricted Stock Award, Gross       $ 421        
Common Stock [Member] | Offering [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Stock Issued During Period, Shares, New Issues 3,007,026 2,221,334            
Class of Warrant or Right, Exercise Price of Warrants or Rights   $ 4.50            
Proceeds from Issuance of Warrants $ 12,800,000 $ 10,000,000            
Warrant [Member] | Offering [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Class of Warrant or Right, Number of Securities Called by Warrants or Rights 1,503,513 1,666,019            
Shares Issued, Price Per Share $ 4.90 $ 4.95            
Warrants and Rights Outstanding, Term 5 years 5 years            
Proceeds from Issuance Initial Public Offering $ 11,624,401 $ 8,800,087            
Amount allocated to share capital 7,016,401 4,617,087            
Amount allocated to warrant liability $ 5,135,000 $ 4,846,000